Topics

Companies Related to "Metformin Treatment related Retinal Degeneration∨derfield=score∨derval=desc" [Most Relevant Company Matches] - Page: 5 RSS

11:53 EDT 22nd July 2019 | BioPortfolio

Here are the most relevant search results for "Metformin Treatment related Retinal Degeneration∨derfield=score∨derval=desc" found in our extensive corporate database of over 50,000 company records.

Showing "Metformin Treatment related Retinal Degeneration derfield score derval" Companies 101–125 of 4,900+

Wednesday 3rd April 2019

Cellgen Diagnostics

Headquartered in Irvine, California with R&D lab facilities located in San Diego, California, Cellgen is focused on developing and commercializing a non-invasive precision medicine platform that can detect circulating nucleic acids, such as mRNA in white blood cells in under 2 hours. Running on its proprietary platform, Cellgen’s disposable cartridge ...


Tuesday 2nd April 2019

QUE Oncology

QUE Oncology, Inc. is a global clinical stage biotechnology company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122 is initially focused on the treatment of hot flashes in breast cancer survivors undergoing hormone therapy. Several clinical studies with Q-122 have shown the drug to be safely administered to over ...

Monday 1st April 2019

Dicerna™ Pharmaceuticals, Inc.

Dicerna™ Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of innovative, subcutaneously delivered RNAi-based therapeutics for the treatment of diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases and viral infectious diseases. Dicerna is leveraging its prop...


Recida Therapeutics, Inc.

Recida Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class anti-infective medicines for the treatment of multidrug-resistant infections. The company is currently advancing its novel LpxC inhibitor, RC-01, in a Phase I clinical trial. Recida is led by an experienced team of pharmaceutical and anti-infectives executives ...

Thursday 28th March 2019

Polyneuron Pharmaceuticals AG

Polyneuron Pharmaceuticals is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases of the nervous system where a pathological role of anti-carbohydrate autoantibodies is well established. The company’s Antibody-Catch™ technology platform enables the chemical design of injectable gly...

Wednesday 27th March 2019

Humacyte Inc.

Humacyte, Inc., a privately held company founded by Dr. Laura E. Niklason, M.D., Ph.D., in 2004, is a medical research, discovery and development company with clinical and pre-clinical stage investigational products. Humacyte is primarily focused on developing and commercializing a proprietary novel technology based on human tissue-based products for key a...

Pulsara

Pulsara provides a real-time communication network across an entire region. The Pulsara platform, built on the power of mobile technology, unites the right clinicians at the right time for the right patient – providing transparency and streamlined communication. Simply CREATE a dedicated patient channel. BUILD the team. And, COMMUNICATE using audio, v...

Juvenescence Ltd

Juvenescence Limited is a life science and biotech company developing therapies to increase healthy human longevity. It was founded by Jim Mellon, Dr. Greg Bailey and Dr. Declan Doogan. The Juvenescence team are highly experienced drug developers, entrepreneurs and investors with a significant history of success in the life sciences sector. Juvenescence ...

Monday 25th March 2019

BrightWater Medical, Inc.

BrightWater Medical is a mid-stage medical device company uniquely positioned to significantly impact the treatment of ureteral blockages by interventional radiologists. The company was founded by Dr. Bob Smouse, Associate Professor of Radiology & Surgery, University of Illinois College of Medicine. Dr. Smouse is a leading interventional radiologist, clini...

Synerkine Pharma B.V.

Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. Synerkine Pharma was founded in 2018 and has licensed the exclusive rights of its lead compound, a fusion protein of IL4 and IL10, from the University Medical Center Utrecht (UMCU), the Netherlands. This fusion protein target...

Thursday 21st March 2019

The Nagourney Cancer Institute

Dr. Robert Nagourney, a board-certified oncologist/hematologist, is the founder and medical laboratory director of the Nagourney Cancer Institute in Long Beach, CA. He has pioneered the use of human tissue studies for individualized treatment selection and spearheaded new drug development using the Ex Vivo Analysis of Programmed Cell Death (EVA/PCD) platfo...

Lead Pharma

Lead Pharma is a pharmaceutical company focusing on the discovery and development of innovative medicines for the treatment of autoimmune diseases and cancer. Lead Pharma’s drug discovery engine combines medicinal, structural, and computational chemistry with molecular pharmacology, cell and tissue-based pharmacology. Lead Pharma has a pipeline of fir...

Wednesday 20th March 2019

The ERP Biomarker Qualification Consortium, LLC

The ERP Biomarker Qualification Consortium, LLC, a subsidiary of Neuronetrix Solutions, LLC (dba Cognision), is a pharmaceutical industry collaboration that was established to formally qualify normative event-related potential (ERP) biomarkers with the goal of advancing and streamlining the clinical development of new investigational therapies for people w...

Tuesday 19th March 2019

SFA Therapeutics

SFA Therapeutics is a bio-pharmaceutical company focused on new advancements in the treatment of inflammatory diseases, targeting NF-κB. Chronic inflammation has been implicated in a wide range of diseases, including rheumatoid arthritis, psoriatic arthritis, lupus (SLE), inflammatory bowel disease (IBD), Crohn's Disease, psoriasis, liver disease a...

Monday 18th March 2019

Matinas BioPharma Holdings, Inc.

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on creating value through the streamlined development of MAT9001 for the treatment of cardiovascular and metabolic conditions and the application of its LNC platform technology to solve complex challenges relating to the safe and effective delivery of small molecules, gene therapies, p...

Thursday 14th March 2019

Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, is currently being evaluated in a Phase III clinical development program. For more information, please visit www.soleno.life.

Adamis Pharmaceuticals Corporation

La Jolla Pharmaceutical Company is a biopharmaceutical company. La Jolla had historically focused substantially all of its research, development and clinical efforts and financial resources toward the development of its Riquent® (abetimus sodium) product candidate, as a treatment for patients with lupus. In February 2009, La Jolla announced that an inde...

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...

Harpoon Therapeutics, Inc.

Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, Ph.D., a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created a novel T-cell recruiting d...

CleanSlate Outpatient Addiction Medicine

A pioneer and leader in outpatient addiction medicine, CleanSlate Outpatient Addiction Medicine is a national medical group which provides treatment for the chronic disease of addiction, primarily opioid and alcohol use disorders. Founded in 2009 in response to the growing opioid epidemic facing the country, the company is a growing, multi-state network of...

EnClear Therapies

EnClear Therapies is a Cambridge (USA) based biotechnology company developing neurology-focused, device-based systems that remove toxic proteins as therapies for the treatment of neurodegenerative diseases and provide closed loop delivery & monitoring of cerebrospinal fluids (CSF). The company’s first products will target improving the lives of patien...

Wednesday 13th March 2019

Openly Rare with Paul Kidwell

Openly Rare with Paul Kidwell is a monthly podcast covering all aspects of rare diseases and will feature conversations with newsmakers and leaders from the world of biomedical and academic research, patient engagement, caregiving, rare disease patients and their families, as well as others who in some way have been touched by the growing number of rare il...

Tuesday 12th March 2019

Vapotherm, Inc.

Vapotherm, Inc. is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1.7 million patients have been treated with Vapotherm Hi-VNI Techn...

Tiburio Therapeutics Inc.

Tiburio is a clinical stage biopharmaceutical company dedicated to advancing novel treatments for rare neuroendocrine tumors and rare endocrine diseases where there is significant patient need. Our pipeline consists of two clinical stage compounds, TBR-760 for the treatment of non-functioning pituitary adenoma (NFPA), and TBR-065 for additional rare endocr...

Genetron Health (Beijjing) Co. Ltd

As a leader in cancer precision medicine in China, Genetron is practicing the research and development concept of “exploration, discovery, application and change”. Genetron offers cancer researchers and health care providers a full cycle of products and services from prevention to treatment, including risk assessment, early screening, molecular d...


More From BioPortfolio on "Metformin Treatment related Retinal Degeneration∨derfield=score∨derval=desc"

Quick Search

Corporate Database Quicklinks